Orchestra BioMed Holdings, Inc. - Ordinary Shares — キャッシュフロー (NASDAQ:OBIO) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー —-272.36 K-1.58 M-46.13 M-50.56 M-48.96 M -54.52 M 投資活動によるキャッシュフロー —092.59 M10.69 M13.09 M-26.94 M -29.62 M 財務活動によるキャッシュフロー —0-92.59 M46.22 M29.17 M88.33 M 94.16 M フリーキャッシュフロー —-272.36 K-1.58 M-46.13 M-50.56 M-49.45 M -55.08 M

ニュース

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates

Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates

NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates

Chardan、Orchestra BioMed株の投資判断を維持、臨床試験に注目

Chardan reiterates Orchestra BioMed stock rating on trial focus

Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates

Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates

Orchestra BioMed to present hypertension therapy data at medical meetings

TD CowenがOrchestra BioMed株を新規の医療機器ポートフォリオでBuy評価開始

TD Cowen initiates Orchestra BioMed stock with Buy rating on novel medical device portfolio

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Beats Revenue Estimates